[Federal Register Volume 87, Number 238 (Tuesday, December 13, 2022)]
[Notices]
[Page 76207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26996]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Sickle Cell Disease 
Advisory Committee.
    The meeting will be open to the public through a virtual meeting. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.
    Date: January 30, 2023.
    Time: 10:00 a.m. to 2:30 p.m.
    Agenda: Research, engagement and representation from the 
community.
    Place: National Institutes of Health, Rockledge 1, 6705 
Rockledge Dr, Bethesda, MD 20892, (Virtual Meeting--Teleconference 
andZoomGov).
    Telephone Access: +1 669 254 5252 (Meeting ID 160 763 2658).
    Virtual Access: https://nih.zoomgov.com/j/1607632658, (Meeting 
ID: 160 763 2658).
    Contact Person: Nahed El Kassar, MD, Ph.D. Medical Officer 
National Heart, Lung, and Blood Institute, Blood Epidemiology & 
Clinical Therapeutics Branch, Division of Blood Diseases and 
Resources, 6701 Rockledge Drive, Suite 9166, Bethesda, MD 20892, 
301-435-0080, [email protected].

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: December 8, 2022.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-26996 Filed 12-12-22; 8:45 am]
BILLING CODE 4140-01-P